Novel Therapeutics in Atopic Dermatitis
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories:
Immune dysregulation
Abnormal skin barrier
Abnormal itch/scratch cycle
Abnormal skin microbiome
In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi …
Atopic dermatitis (AD) is a chronic inflammatory skin disease. The pathogenesis of AD is complex with many mediators involved and can be broken down into 4 categories:
Immune dysregulation
Abnormal skin barrier
Abnormal itch/scratch cycle
Abnormal skin microbiome
In AD, there is a breakdown in molecular control of the immune system, leading to overproduction and expressi … 
I believe one of the most valuable aspects of attending conferences such as ODAC is to “fill in the gaps” in important topics that are often missing in our regular dermatology training. While US dermatology residency programs provide the foundation for providing the highest level of dermatologic care to our patients, they are often lacking in teaching the business side of medicine and practica … 
The following is a summary of one of the many Q&A sessions held during the 2020 Skin of Color Virtual Update. During this particular session, questions were moderated by SOCU Co-Chair Dr. Andrew Alexis and answered by Drs. Ginette Okoye and Candrice Heath. The audience posed important questions and the faculty offered insightful answers regarding atopic dermatitis, hidradenitis suppurativa, h … 
The title of today’s broadcast: Practical Applications of Lasers and Energy-Based Modalities in Skin of Color. That is a mouth-full to basically tell us that we are getting the best tips to treat refractory medical and aesthetically-concerning conditions from 3 of dermatology’s foremost experts in skin of color: Dr. Eliot Battle, Dr. Cheryl Burgess, and Dr. Andrew Alexis.
WOW! We were in fo … 
Next Steps in Derm author and Derm In-Review Advisory Council member, Dr. Cula Dautriche, reached out to Dr. Daniel Siegel, former president of the American Academy of Dermatology (AAD), to shed some light on some of the challenges facing the field of dermatology today. Dr. Siegel is currently the chair of the Council on Corporate, Community and Philanthropic Relations of the AAD and remains heav … 